SENEX Retatrutide GLP-3 5 mg
Shipping & Delivery
Orders are usually shipped the next business day from our EU warehouse - neutrally packaged and discreet. Shipping is free for orders over €200, and every order includes free BAC water.
Payment
Secure payment via DHL cash on delivery, crypto payment or bank transfer. Data protection, confidentiality and secure processing are always our top priority.
Quality & COA
Each batch is independently tested – in cooperation with Janoshik Laboratories in Prague. You can find the corresponding certificates of analysis (COA) on our Certificates page. All products are provided exclusively for research and analytical purposes.
SENEX Retatrutide GLP-3 5 mg – high-purity research peptide
Retatrutide is one of the most discussed compounds in current peptide research. The 5 mg size is the smallest unit in the SENEX range – with a batch-specific certificate of analysis from Janoshik, exclusively for scientific, analytical, and research purposes.
What is Retatrutide?
Retatrutide is a synthetically produced peptide and is described in the literature as a triple agonist. Unlike earlier compounds of this substance class, it binds to three receptors:
- GLP-1 – Glucagon-like Peptide-1
- GIP – glucose-dependent insulinotropic polypeptide
- Glucagon
This multi-binding is why Retatrutide is often referred to in research by the abbreviation GLP-3 – as a designation for the third stage of development after single and dual receptor agonists.
A detailed classification of the terms and the state of research can be found in the article What is Retatrutide?
Classification: GLP-1, GLP-2 and GLP-3
The commonly used abbreviations refer to the number of receptors addressed, not to related hormones:
- GLP-1 – Single agonist. Binds exclusively to the GLP-1 receptor.
- GLP-2 – Dual agonist. Binds to GLP-1 and GIP.
- GLP-3 – Triple agonist, Retatrutide. Binds to GLP-1, GIP and Glucagon.
The difference between the stages lies in the receptor profile. The consequences thereof are the subject of ongoing investigations.
State of Research
Retatrutide is in clinical development and is currently not approved as a medicine in any country. Accordingly, there is no officially reviewed application and no reviewed dosage. Published data comes from ongoing clinical trial programs and is available through relevant specialized databases.
Quality and Analytics
- High laboratory purity
- Batch-specific Certificate of Analysis (COA) from Janoshik
- Clearly declared composition
- Reproducible production standards
The certificates of analysis can be viewed in the Certification section.
Buy Retatrutide GLP-3 from SENEX
Shipping within the EU on the next business day, discreetly packaged. Free shipping from €200, BAC water is included with every order. Larger units: 10 mg and 20 mg. Other compounds in this area in the collection Metabolism & Metabolic Support.
Intended Use
The products offered by SENEX are exclusively for scientific, analytical, and research purposes. They are not intended for human or animal consumption and may only be used within the scope of permissible research and analytical purposes.
Shipping
Next business day shipping from our EU warehouse - discreet and neutrally packaged. Free shipping for orders over €200, free BAC water with every order.
Payment
Secure payment via DHL cash on delivery, crypto payment or bank transfer.
Quality & COA
Every batch is independently tested - in cooperation with Janoshik Laboratories in Prague. The Certificates of Analysis (COA) can be found on our certificates page.
Important Note
All products are provided exclusively for research and analytical purposes and are not intended for human consumption.
